MX2024002190A - Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes. - Google Patents

Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes.

Info

Publication number
MX2024002190A
MX2024002190A MX2024002190A MX2024002190A MX2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A
Authority
MX
Mexico
Prior art keywords
fucan
transplants
treatment
compositions
conditions related
Prior art date
Application number
MX2024002190A
Other languages
English (en)
Spanish (es)
Inventor
Christopher Michael Kevin Springate
Ian Millet
Hesong Sun
Original Assignee
Arc Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arc Medical Inc filed Critical Arc Medical Inc
Publication of MX2024002190A publication Critical patent/MX2024002190A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2024002190A 2021-08-20 2022-08-18 Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes. MX2024002190A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163235316P 2021-08-20 2021-08-20
US202263354322P 2022-06-22 2022-06-22
PCT/CA2022/051254 WO2023019360A1 (en) 2021-08-20 2022-08-18 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Publications (1)

Publication Number Publication Date
MX2024002190A true MX2024002190A (es) 2024-06-24

Family

ID=85239322

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024002190A MX2024002190A (es) 2021-08-20 2022-08-18 Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes.

Country Status (10)

Country Link
US (1) US20240350531A1 (enExample)
EP (1) EP4387630A4 (enExample)
JP (1) JP2024532867A (enExample)
KR (1) KR20240087708A (enExample)
AU (1) AU2022328865A1 (enExample)
CA (1) CA3229366A1 (enExample)
IL (1) IL310940A (enExample)
MX (1) MX2024002190A (enExample)
WO (1) WO2023019360A1 (enExample)
ZA (1) ZA202401941B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024104757B4 (de) * 2024-02-21 2026-03-26 Acandis Gmbh Medizinische Vorrichtung mit verbesserter antithrombotischer Wirkung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933290B2 (en) * 2007-06-26 2015-01-13 Sofradim Production Sas Mesh implant
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
JP7272707B2 (ja) * 2018-07-27 2023-05-12 エーアールシー メディカル デバイス,インク. 線維性癒着の処置のための高硫酸化フカン

Also Published As

Publication number Publication date
AU2022328865A1 (en) 2024-03-14
EP4387630A4 (en) 2025-07-30
CA3229366A1 (en) 2023-02-23
ZA202401941B (en) 2025-06-25
IL310940A (en) 2024-04-01
EP4387630A1 (en) 2024-06-26
KR20240087708A (ko) 2024-06-19
US20240350531A1 (en) 2024-10-24
JP2024532867A (ja) 2024-09-10
WO2023019360A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
Campoccia et al. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces
Sobczak et al. Hirudotherapy in veterinary medicine
MX2021012558A (es) Metodos innovadores para el tratamiento de las semillas y componentes para mejorar los atributos y el rendimiento de la planta.
Gostyński et al. Successful therapeutic transplantation of revertant skin in epidermolysis bullosa
Hinck et al. Use of vacuum-assisted closure negative pressure wound therapy in combat-related injuries—literature review
CA2656523A1 (en) Flexible bioresorbable hemostatic packing and stent
Chen et al. Treatment of severe burn with DermACELL®, an acellular dermal matrix
AR084753A1 (es) Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)
WO2012009377A3 (en) Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
MX2021013323A (es) Composiciones microbianas y metodos de uso para favorecer el crecimiento de las plantas y tratar las enfermedades de las plantas.
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
IN2014MN01981A (enExample)
MX2022009807A (es) Metodos para tratar y prevenir arritmias por injerto.
BRPI0612931B8 (pt) composição para aplicação na pele
ZA202401941B (en) Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants
Akhtar et al. Inferiorly based thigh flap for reconstruction of defects around the knee joint
CN103636596A (zh) 一种生物膜保护液及其制备与应用
Hashemi et al. A human acellular dermal matrix coated with zinc oxide nanoparticles accelerates tendon repair in patients with hand flexor tendon injuries in zone 5 of the hand
Vallet-Regí et al. New materials and complications of prostheses in humans: situation in Spain
Ellis John Hunter's teachings on gunshot wounds
Ramdas et al. Temporary ectopic testicular replantation, refabrication and orthotopic transfer
Al Hussein et al. Minimally invasive surgical protocol for adipose derived stem cells collection and isolation-ovine model
Sylvester-Hvid et al. Benign tumours leading to total penile denudation treated with Manuka honey dressings: A case report and review of literature
Lander et al. Autologous stromal vascular fraction containing stem cells combined with low intensity shock wave for the treatment of human erectile dysfunction